Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Brooks Osburn

Neurological Surgery Temple Terrace, FL Medical Doctor

NPI 1932527298 CMS profile 2788927

5901 E Fowler Ave Ste 100, Temple Terrace, FL 33617

Open in the dashboard

General payments

$63,283

199 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$44,905 paid to institutions, not to them · program years 2023–2024

Through program year 2025, Brooks Osburn of Temple Terrace, FL is reported in the CMS Open Payments database as having received $63,283 across 199 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $44,905 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 88th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,624 27
2024 General $8,915 39
2023 General $10,994 63
2022 General $16,594 43
2021 General $7,156 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brooks Osburn
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Brooks Osburn were reported at $19,624. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Brooks Osburn Neurological Surgery median Middle half National median
2019 $0 $582 $138–$3,006 $163
2020 $0 $294 $76–$2,174 $114
2021 $7,156 $387 $105–$2,432 $132
2022 $16,594 $542 $139–$2,989 $149
2023 $10,994 $534 $145–$2,697 $160
2024 $8,915 $574 $155–$3,046 $164
2025 $19,624 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $25,548 46 payments
  2. Carlsmed, Inc. $18,475 18 payments
  3. Pacira Pharmaceuticals Incorporated $6,863 5 payments
  4. Alphatec Spine, Inc $6,403 12 payments
  5. DePuy Synthes Sales Inc. $1,672 47 payments
  6. Medtronic, Inc. $895 17 payments
  7. Spinal Elements, Inc. $850 9 payments
  8. Abbott Laboratories $710 17 payments
  9. Stryker Corporation $364 4 payments
  10. 4WEB, Inc. $311 1 payment
  11. Other $1,192 23 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $39,389 9 payments
  2. Travel and Lodging $14,752 28 payments
  3. Food and Beverage $9,142 162 payments
Products named General payments · program years 2021–2025
  1. aprevo $18,369 16 payments
  2. Exparel $6,863 5 payments
  3. Other - Miscellaneous $5,243 6 payments
  4. CONDUIT $3,201 14 payments
  5. Zilretta $1,717 2 payments
  6. Iovera $1,717 2 payments
  7. Teligen $1,716 19 payments
  8. Medical Device $565 5 payments
  9. PROCLAIM $465 14 payments
  10. MAZOR X SYSTEM $389 8 payments
  11. Other $4,678 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

139

Median for Neurosurgery: 83

Drug cost

$2,079

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 32 $696
Celecoxib Generic 12 $658
Gabapentin Generic 29 $384
Cyclobenzaprine Hcl Generic 11 $122
Methylprednisolone Generic 14 $114
Meloxicam Generic 27 $68
Tramadol Hcl Generic 14 $37

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 81 billing codes

Paid by Medicare

$174,147

Medicare's payments for the services billed

Medicare patients

307

Average age 73

Services billed

1,460

180 women, 127 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 36%
Diabetes 34%
Depression 32%
Osteoporosis 31%
Chronic kidney disease 25%
COPD 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

199 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record